Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Eydo Pharma SAS - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11301
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Eydo Pharma SAS (Eydo Pharma) develops anti-bacterial medicines from essential oils and natural plant molecules for the treatment of infections caused by resistant bacteria. The company developed a pipeline of compounds and formulations such as EP1012, EP1010, EP1011, EP1014, EP1015, EP1020 and EP1030 to treat multi-antibiotic resistant infections, pathogenic bacterial strains and hospital acquired infections (HAI, nosocomial diseases). Its proprietary drug delivery technologies for the in vivo delivery of therapeutic lipophilic and active compounds include Aquaphile system, Lipidic Nano Capsules and Nano Beads through routes of administration such as intravenous and oral. The company works in partnership with universities and research centers including Inserm (French National Institute of Health and Medical Research). Eydo pharma is headquartered in Chartres, France.

Eydo Pharma SAS – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eydo Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Eydo Pharma Raises Funds in Financing 10
Eydo Pharma Raises Funds in Second Round Financing 11
Eydo Pharma Raises Funds in First Round Financing 12
Eydo Pharma SAS – Key Competitors 13
Eydo Pharma SAS – Key Employees 14
Eydo Pharma SAS – Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Key Facts 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eydo Pharma SAS, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eydo Pharma SAS, Deals By Therapy Area, 2012 to YTD 2018 8
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Eydo Pharma Raises Funds in Financing 10
Eydo Pharma Raises Funds in Second Round Financing 11
Eydo Pharma Raises Funds in First Round Financing 12
Eydo Pharma SAS, Key Competitors 13
Eydo Pharma SAS, Key Employees 14
Eydo Pharma SAS, Other Locations 15

List of Figures
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Eydo Pharma SAS, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Eydo Pharma SAS:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Astaldi S.p.A.:戦略・SWOT・企業財務分析
    Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Astaldi S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Industrial Bank Of Korea:企業の戦略・SWOT・財務分析
    Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report Summary Industrial Bank Of Korea - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Jack in the Box Inc (JACK):企業の財務・戦略的SWOT分析
    Jack in the Box Inc (JACK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Hindustan Petroleum Corp Ltd (HINDPETRO):企業の財務・戦略的SWOT分析
    Hindustan Petroleum Corp Ltd (HINDPETRO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Titan Pharmaceuticals Inc (TTNP):医療機器:M&Aディール及び事業提携情報
    Summary Titan Pharmaceuticals Inc (Titan) is a pharmaceutical company that develops therapeutics for the treatment of serious medical disorders. The company develops drugs using ProNeura, a proprietary drug delivery platform, for the treatment of chronic diseases. It product portfolio provides probu …
  • STP&I Public Company Limited:企業の戦略・SWOT・財務情報
    STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report Summary STP&I Public Company Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Alliance Oil Co Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Alliance Oil Company Ltd (AOC) is an integrated oil and gas company. It explores for, extracts, and produces crude oil and gas; refines oil; and transports and sells oil products. The company has oil and gas exploration and production fields in the Timano-Pechora, Volga-Urals and Tomsk regio …
  • Printpack Inc:企業の戦略的SWOT分析
    Printpack Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Iberia Lineas Aereas de Espana, SA:企業のM&A・事業提携・投資動向
    Iberia Lineas Aereas de Espana, SA - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iberia Lineas Aereas de Espana, SA Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on m …
  • Veeco Instruments Inc (VECO):企業の財務・戦略的SWOT分析
    Summary Veeco Instruments Inc (Veeco) is a technology company that designs, manufacture and markets thin film and semiconductor equipment. The company offers various products and technologies which include MOCVD systems, precision surface processing system, MBE technologies, and ion beam sputtering. …
  • Time Inc.:企業のM&A・事業提携・投資動向
    Time Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Time Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Soil Machine Dynamics Ltd:企業の戦略的SWOT分析
    Soil Machine Dynamics Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Sterling Energy plc (SEY):企業の財務・戦略的SWOT分析
    Summary Sterling Energy Plc (Sterling) is an oil and gas company that offers oil and gas exploration and development services. The company acquires, produces, operates, manages, and develops crude oil and natural gas producing assets. It operates and manages oil and gas exploration projects such as …
  • Eisai Inc:企業のM&A・事業提携・投資動向
    Eisai Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Eisai Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capita …
  • Gem Pharmaceuticals LLC-製薬・医療分野:企業M&A・提携分析
    Summary Gem Pharmaceuticals LLC (Gem Pharmaceuticals) is a clinical-stage biopharmaceutical company that develops proprietary anthracycline derivatives. The company’s pipeline products include GPX-150 for oncology, topical GPX-150 for inflammation, GPX 150 oral formulations and potency analogues pro …
  • MedDay SA-製薬・医療分野:企業M&A・提携分析
    Summary MedDay SA (MedDay) is a biotechnology company that develops drugs for brain metabolism to treat diseases of the nervous system. The company provides clinical and pharmaceutical development in the field of rare inborn errors of metabolism. Its pipeline products include molecules such as MD100 …
  • Sacgasco Ltd (SGC):企業の財務・戦略的SWOT分析
    Summary Sacgasco Ltd (Sacgasco) formerly Australian Oil Company Ltd, is an energy company that provides conventional oil and gas exploration, development and production across Australia. The company develops and produces clean natural gas in the Sacramento Basin, onshore California. It explores Sacr …
  • Quanta Services Inc (PWR):企業の財務・戦略的SWOT分析
    Quanta Services Inc (PWR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • EBS Technologies GmbH:医療機器:M&Aディール及び事業提携情報
    Summary EBS Technologies GmbH (EBS) is a medical device company that develops stimulation system for visual field effect. The company offers Eyetronic Therapy, which has been developed for patients suffering from a progressive visual field loss due to glaucoma and other diseases of the optic nerve. …
  • CK Infrastructure Holdings Ltd (1038):石油・ガス:M&Aディール及び事業提携情報
    Summary CK Infrastructure Holdings Limited (CKI), a subsidiary of CK Hutchison Holdings Limited, is an infrastructure investment company. It holds diversified investment interests across various sectors including energy, rail transportation, water, waste management, and other infrastructure related …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆